1 Green Flag for AbbVie in 2022 and 1 Red Flag
If there was one area of optimism in this market since the start of the year, I'd have to say it was healthcare. The S&P 500 healthcare sector grew 2.7% -- until the first week of April hit. Then the bottom dropped out. Yet, year-to-date the healthcare sector is still down only 6% in 2022 vs. a 13.5% decline for the broader S&P 500.
In the case of AbbVie (NYSE: ABBV), its shares have dropped 15.5% since the start of the year, due not only to the broader market decline but also because of challenges facing a top-selling product. But there's reason to believe that both obstacles can be overcome.
Image source: Getty Images.
Source Fool.com
